Post thaw assessment of umbilical cord blood
Post thaw assessment of umbilical cord blood
批准号:
8261833
负责人:
ALLISON HUBEL
金额:
$11.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-15 至 2014-03-31
关键词:
AdultAnimalsApoptosisBiological AssayBiological PreservationCD34 geneCell AgingCell CountCellsCollectionColony-Forming Units AssayColony-forming unitsCryopreservationDevelopmentDiseaseEngraftmentExhibitsFlow CytometryFreezingGenotypeHematopoieticHematopoietic NeoplasmsHematopoietic stem cellsHumanImmuneImmunotherapyInvestigationKineticsLifeLymphocyteMapsMeasuresMembraneMesenchymal Stem CellsMethodsMetricModelingMonitorMononuclearNational Heart, Lung, and Blood InstituteOutcome StudyPhaseProcessQuality ControlRecoveryRegenerative MedicineReportingRiskSiteSourceStaining methodStainsStem cell transplantTemperatureTestingTherapeutic UsesTimeTransplantationUmbilical Cord BloodUnited States Food and Drug AdministrationVariantWhole Bloodannexin A5biobankcaspase-3cell ageclinical applicationclinically relevantexperiencefunctional disabilityimprovedmonocytepathogenprogramsstandard measuretransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary. The long term objective of this investigation is to develop methods of post-thaw assessment that permit transplant sites to assess umbilical cord blood units (UCB) prior to transplant and can be used by UCB banks as a part of their quality control program. UCB is an important source of hematopoietic stem cells (HSCs) used in the treatment of a variety of diseases including blood cancer. UCB now comprises 28% of all HSC transplants performed in the USA every year, with 14,000 transplants to date performed in humans worldwide. The advantages of UCB are numerous: it can be collected at no risk to the donor; immediate availability in a bank; wider availability of diverse HLA genotypes with approximately 350,000 units banked; lower immune reactivity and lower inherent pathogen transmission. All indications are that the clinical applications for UCB will continue to grow. The vast majority of UCB units are collected and cryopreserved for later use. Considerable effort has been invested to improve the quality of UCB units by standardizing collection, processing and preservation. In spite of the aforementioned efforts in standardizing UCB processing, there have been reports of poor post thaw recovery of UCB units. There is not yet a standard metric or measure by which to quantify post-thaw potency of UCB products. Transplant studies of UCB suggest that both CD34+ and colony forming unit (CFU) content correlate with engraftment and long- term survival. Both of these assays are candidates for assessing post-thaw function. Hematopoietic cell products exhibit significant cell losses resulting
from post-thaw apoptosis. More recent studies demonstrated that cells expressing early signs of apoptosis did not engraft in an animal transplant model suggesting significant functional impairment of the cells. Therefore, characterizing post-thaw apoptosis may be a clinically relevant post-thaw quality metric for UCB. Post thaw apoptosis may also be a marker for aging of the cells during storage. It is our hypothesis that post-thaw apoptosis measures can be a clinically relevant metric for damage during the preservation process and storage of UCB units.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multicomponent solutions for the preservation of cell therapy products
-
批准号:10439717
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2017
-
负责人:ALLISON HUBEL
-
依托单位:
Multicomponent solutions for the preservation of cell therapy products
-
批准号:10636645
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2017
-
负责人:ALLISON HUBEL
-
依托单位:
Multicomponent solutions for the preservation of cell therapy products
-
批准号:10200145
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2017
-
负责人:ALLISON HUBEL
-
依托单位:
Integrated training in development and clinical practice of cell-based therapies
-
批准号:9127354
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2015
-
负责人:ALLISON HUBEL
-
依托单位:
Integrated training in development and clinical practice of cell-based therapies
-
批准号:9487293
-
项目类别:
-
资助金额:$10.83万
-
财政年份:2015
-
负责人:ALLISON HUBEL
-
依托单位:
Integrated training in development and clinical practice of cell-based therapies
-
批准号:9283633
-
项目类别:
-
资助金额:$11.07万
-
财政年份:2015
-
负责人:ALLISON HUBEL
-
依托单位:
Technology platform for development of multi-component preservation solution
-
批准号:8582171
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2013
-
负责人:ALLISON HUBEL
-
依托单位:
Technology platform for development of multi-component preservation solution
-
批准号:8703695
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2013
-
负责人:ALLISON HUBEL
-
依托单位:
Post thaw assessment of umbilical cord blood
-
批准号:8457137
-
项目类别:
-
资助金额:$10.85万
-
财政年份:2012
-
负责人:ALLISON HUBEL
-
依托单位:
Cell Graft Engineering Using Microfluids
-
批准号:7229928
-
项目类别:
-
资助金额:$17.91万
-
财政年份:2006
-
负责人:ALLISON HUBEL
-
依托单位:
Cell Graft Engineering Using Microfluids
-
批准号:7029804
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2006
-
负责人:ALLISON HUBEL
-
依托单位:
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS
-
批准号:2771068
-
项目类别:
-
资助金额:$10.09万
-
财政年份:1996
-
负责人:ALLISON HUBEL
-
依托单位:
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS
-
批准号:2519076
-
项目类别:
-
资助金额:$10.1万
-
财政年份:1996
-
负责人:ALLISON HUBEL
-
依托单位:
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS
-
批准号:6181073
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1996
-
负责人:ALLISON HUBEL
-
依托单位:
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS
-
批准号:2023562
-
项目类别:
-
资助金额:$10.26万
-
财政年份:1996
-
负责人:ALLISON HUBEL
-
依托单位:
CRYOBIOPHYSICAL CHARACTERISTICS OF SPHEROIDS
-
批准号:6019216
-
项目类别:
-
资助金额:$9.88万
-
财政年份:1996
-
负责人:ALLISON HUBEL
-
依托单位:
海外基金